Do we need prognostic factors in nodal-negative breast cancer?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Do we need prognostic factors in nodal-negative breast cancer?

Published:2000-02 Issue:3 Volume:36 Page:302-306
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Hayes D.F

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference13 articles.

1. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer;J. Clin. Oncol,1996

2. 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer;J. Clin. Oncol.,1997

3. Meeting highlights;Goldhirsch;J. Natl. Cancer Inst.,1998

4. Design and conduct of clinical trials;Simon,1993

5. Tamoxifen for early breast cancer;Lancet,1998

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging transcriptomics for precision diagnosis: Lessons learned from cancer and sepsis;Frontiers in Genetics;2023-03-10

2. Oncotype DX for Comprehensive Treatment in Male Breast Cancer: A Case Report and Literature Review;American Journal of Men's Health;2019-05

3. Adjuvant Systemic Treatment in Hormone Receptor Positive, HER2 Negative Breast Cancer;Breast Cancer and Surgery;2018-11-21

4. Prognostic Tests for Estrogen Receptor–Positive Breast Cancer;JAMA Oncology;2016-02-01

5. Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomes;Breast Cancer: Targets and Therapy;2015-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP